Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53,599Revenue $M10,764Net Margin (%)33.0Altman Z-Score5.7
Enterprise Value $M54,285EPS $15.3Operating Margin %45.4Piotroski F-Score7
P/E(ttm)16.1Beneish M-Score-2.8Pre-tax Margin (%)44.3Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %26.5Quick Ratio3.2Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %25.5Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow19.0y-y EBITDA Growth Rate %32.8ROA % (ttm)20.5Higher Current Ratio y-yY
Dividend Yield %--PEG0.7ROE % (ttm)32.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M223ROIC % (ttm)34.2Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBVanguard Health Care Fund 2015-12-31 Add0.09%$256.04 - $309.67
($287.66)
$ 245.11-15%Add 3.91%3,810,023
BIIBKen Fisher 2015-12-31 Reduce$256.04 - $309.67
($287.35)
$ 245.11-15%Reduce -1.75%110,475
BIIBMario Gabelli 2015-12-31 Add$256.04 - $309.67
($287.66)
$ 245.11-15%Add 0.17%4,805
BIIBVanguard Health Care Fund 2015-09-30 Add1.19%$272.28 - $409.5
($330.23)
$ 245.11-26%Add 105.96%3,666,723
BIIBJoel Greenblatt 2015-09-30 Buy 0.03%$272.28 - $409.5
($330.23)
$ 245.11-26%New holding9,410
BIIBKen Fisher 2015-09-30 Add0.02%$272.28 - $409.5
($330.23)
$ 245.11-26%Add 38.94%112,448
BIIBRon Baron 2015-09-30 Add$272.28 - $409.5
($330.23)
$ 245.11-26%Add 29.20%11,814
BIIBVanguard Health Care Fund 2015-06-30 Add1.17%$373.93 - $430.96
($401.66)
$ 245.11-39%Add 425.02%1,780,330
BIIBMario Gabelli 2015-06-30 Reduce$373.93 - $430.96
($401.66)
$ 245.11-39%Reduce -2.74%4,797
BIIBKen Fisher 2015-06-30 Reduce$373.93 - $430.96
($401.66)
$ 245.11-39%Reduce -0.16%80,932
BIIBVanguard Health Care Fund 2015-03-31 Buy 0.31%$334.65 - $475.98
($394.14)
$ 245.11-38%New holding339,100
BIIBJoel Greenblatt 2015-03-31 Sold Out -0.014%$334.65 - $475.98
($394.14)
$ 245.11-38%Sold Out0
BIIBMario Gabelli 2015-03-31 Reduce$334.65 - $475.98
($394.14)
$ 245.11-38%Reduce -0.06%4,932
BIIBKen Fisher 2015-03-31 Add$334.65 - $475.98
($394.14)
$ 245.11-38%Add 2.28%81,058
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 245.11-24%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 245.11-24%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 245.11-24%Reduce -84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 245.11-26%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 245.11-26%Reduce -58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 245.11-26%New holding31,391
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sandrock AlfredEVP CMO Neuro & Neurodegenerat 2016-02-09Sell852$246.54-0.58view
Sandrock AlfredEVP CMO Neuro & Neurodegenerat 2015-12-04Sell441$277-11.51view
Karaboutis AdrianaEVP, Tech. and Bus. Solutions 2015-12-02Sell48$289.14-15.23view
DENNER ALEXANDER JDirector 2015-10-23Buy310,000$277.47-11.66view
Karaboutis AdrianaEVP, Tech. and Bus. Solutions 2015-10-05Sell269$291.43-15.89view
Karaboutis AdrianaEVP, Tech. and Bus. Solutions 2015-10-02Sell417$283.38-13.5view
PAPADOPOULOS STELIOSDirector 2015-07-27Buy10,000$304.88-19.6view
Posner Brian SDirector 2015-06-22Sell470$415-40.94view
WILLIAMS DOUGLAS EEVP Research & Development 2015-06-19Sell3,841$410-40.22view
Posner Brian SDirector 2015-06-15Sell400$386.64-36.61view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist Feb 10 2016 
Jean Hynes Finds Her Pot of Gold Jan 07 2016 
Vanguard Raises Stakes in Biogen, Mylan, Merck Nov 15 2015 
Biogen Among Murray Stahl's Holdings With Growing Earnings Nov 11 2015 
Biogen Is a Bargain Oct 29 2015 
Market Has Overreacted in Biogen Oct 14 2015 
Frank Sands' Undervalued Holdings With Growing EPS Oct 12 2015 
The Undervalued Stocks Among Richard Snow's Recent Buys Sep 17 2015 
The Best Companies of the Pharmaceuticals Industry – August 2015 Aug 18 2015 
Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 

More From Other Websites
Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
Relypsa: This Biotech Just Released Stunning Data Feb 10 2016
Major Biotech Short Interest Continues to Be Mixed Feb 10 2016
Biotech ETFs Slide as Stocks Report Mixed Q4 Results Feb 09 2016
BIOGEN INC. Financials Feb 09 2016
#1 Rated Biotech Analyst on the Sell-Off Feb 08 2016
AGTC Announces Financial Results for the Quarter Ended December 31, 2015 Feb 08 2016
Avoid biotech until elections? Analyst's view Feb 08 2016
Biogen joins international effort to share preclinical data Feb 08 2016
Biogen Joins Pioneering Target Validation Collaboration Feb 08 2016
Biogen Joins Pioneering Target Validation Collaboration Feb 08 2016
Biogen (BIIB) Stock Gets ‘Market Perform’ Rating at Leerink Feb 05 2016
​Three things Biogen is more worried about this year than it was in 2015 Feb 05 2016
Leerink Is Back On Board The Biotech Train Feb 05 2016
Technical Recap on Biotechnology Equities -- Biogen, Medivation, Grifols, and Agios Pharma Feb 05 2016
Biogen to Present at the Leerink Partners 5th Annual Global Healthcare Conference Feb 04 2016
It’s Time to Buy This Biotech Gem Feb 04 2016
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Intrexon and NewLink Feb 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK